pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,258 catalysts · 5,256 phase readout · 2,332 8k filing · 321 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 61 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: approval×type: phase readout×type: filing×clear all
type
  • phase readout5,256
  • 8k filing2,332
  • pdufa321
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07433231: Magnesium Sulfate Versus Other Anesthesia Drugs to Reduce Agitation After Adenotonsillectomy in Pediatric Patients

Sponsor: Ayfer Kaya Gök. Phase: NA. Conditions: Anesthesia Emergence Delirium, Adenotonsillar Hypertrophy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07611331: Single-Layer Versus Double-Layer Uterine Closure After Primary Cesarean Section

Sponsor: Hédi Chaker Hospital. Phase: NA. Conditions: Cesarean Scar Defect (Isthmococele), Pelvic Pain, Spotting, Amenorrhea Secondary, Metrorrhagia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07089953: Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits: a Randomized Controlled Trial (EHR Study #3)

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Communication Skills, Professionalism, Randomized Controlled Trial, Perception

full page →ctgov ↗
›COMPLETEDphase readoutNCT03083353: Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation

Sponsor: Jasper A. Smits. Phase: EARLY_PHASE1. Conditions: Nicotine Dependence, Smoking, Cigarette, Smoking Cessation, Smoking Behaviors, Smoking Reduction, Craving

full page →ctgov ↗
›RECRUITINGphase readoutNCT05093153: Spanish Registry of Patients With IgM Monoclonal Gammopathies

Sponsor: Fundación Española de Hematología y Hemoterapía. Phase: . Conditions: Waldenstrom Macroglobulinemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT05650853: Exploration of eJaculatory Anatomy Concept Study (EJAC Study)

Sponsor: Clinique Pasteur. Phase: NA. Conditions: Ejaculatory Dysfunction

full page →ctgov ↗
›RECRUITINGphase readoutNCT07588737: Multimodal AI-Guided Recovery Management After Lung Cancer Surgery

Sponsor: The First Affiliated Hospital of Guangzhou Medical University. Phase: NA. Conditions: Postoperative Care, Rehabilitation, Artificial Intelligence (Al), Randomized Controlled Trial (RCT)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07530237: Efficacy of Periarticular Vasoconstrictor Infiltration (PVI) in Reducing Bleeding and Postoperative Pain in Lumbar Fusion Surgery

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. Phase: . Conditions: Intraoperative Bleeding in Lumbar Spine Surgery, Postoperative Pain in Lumbar Spine Surgery

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07587437: Preoperative Use of a Magnetically Controlled Capsule Endoscopy in Patients Undergoing Bariatric Surgery

Sponsor: Jerry Dang. Phase: NA. Conditions: Obesity, Bariatric Surgery Candidate, Hypertension, Diabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT05751837: Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal Tumors

Sponsor: Patrick Wagner, MD, FACS. Phase: PHASE1. Conditions: Abdominal Cancer, Malignancy

full page →ctgov ↗
›COMPLETEDphase readoutNCT05895929: The Role of IL5 in Epithelial Cell Integrity

Sponsor: Johns Hopkins University. Phase: EARLY_PHASE1. Conditions: Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis (Diagnosis)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07582731: A Multi-Center Randomized Controlled Trial on the Impact of Disease Subtype-Based Active Video Education on Bowel Preparation Quality in Patients With Inflammatory Bowel Disease

Sponsor: Jie Liang. Phase: NA. Conditions: Inflammatory Bowel Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT06118931: Time-restricted Eating, Window Timing, Type 2 Diabetes Status and Sex on Glycemic Control

Sponsor: University of Toronto. Phase: NA. Conditions: Diabetes Mellitus, Type 2, Obesity, Prediabetic State, Hyperglycemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07470502: MICI-BIO: Study on Patient With Chronic Inflammatory Bowel Disease

Sponsor: Meyer Children's Hospital IRCCS. Phase: NA. Conditions: IBD (Inflammatory Bowel Disease)

full page →ctgov ↗
›RECRUITINGphase readoutNCT04368702: CONFIRM: Magnetic Resonance Guided Radiation Therapy

Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Gastric Cancer, Invasive Breast Cancer, in Situ Breast Cancer, Mantle Cell Lymphoma, Larynx Cancer, Bladder Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07379502: Endometrial Response in Polycystic Ovarian Syndrome Treated With Letrozole Alone or With Added Estradiol Valerate

Sponsor: CMH Kharian Medical College. Phase: NA. Conditions: PCOS (Polycystic Ovary Syndrome)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07491445: Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Sponsor: Revolution Medicines, Inc.. Phase: PHASE3. Conditions: Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Adenocarcinoma Metastatic, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06441435: The Effect of AC-134 in Chronic Kidney Diseases

Sponsor: Taichung Veterans General Hospital. Phase: NA. Conditions: Nephrology

full page →ctgov ↗
›RECRUITINGphase readoutNCT06835725: Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer

Sponsor: British Columbia Cancer Agency. Phase: PHASE2. Conditions: Prostate CA

full page →ctgov ↗
›RECRUITINGphase readoutNCT05739825: Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Clostridioides Difficile Infection Recurrence

full page →ctgov ↗
›RECRUITINGphase readoutNCT07215325: Got Doxy- 'Flipping the Script' on STI PEP

Sponsor: Emory University. Phase: PHASE4. Conditions: Sexually Transmitted Infections (STI)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06044025: A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy

Sponsor: University of Arkansas. Phase: PHASE1. Conditions: Castration Sensitive Prostate Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07471425: Survival Without Persistent Limiting Toxicity: Real Life Prospective Cohort of Advanced Neuroendocrine Tumor

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris. Phase: . Conditions: Neuroendocrine (NE) Tumors

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06800508: Primary and Secondary Stability of a One-Piece Compressive Implant System

Sponsor: University of Sulaimani. Phase: . Conditions: Dental Implant

full page →ctgov ↗
›RECRUITINGphase readoutNCT01617408: Brain Stimulation and Vision Testing

Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: fMRI, Dorsal Pathway, Ventral Pathway

full page →ctgov ↗
›RECRUITINGphase readoutNCT07680725: The Effect of Bottle PEP Exercise on Expiratory Muscle Thickness, Strength, and Balance Parameters in Parkinson's Disease Patients

Sponsor: Marmara University. Phase: . Conditions: Parkinson Disease (PD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT06532240: Methylene Blue for the Treatment of Septic Shock

Sponsor: Northern Jiangsu People's Hospital. Phase: PHASE3. Conditions: Septic Shock

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07572240: A Clinical Trial to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attention, Focus, and Memory in Stressed But Otherwise Healthy Individuals

Sponsor: Rousselot BVBA. Phase: NA. Conditions: Healthy, Stress

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05945550: Comparison of Complication Rates Between Initial and Re-operative Anterior Lumbar Interbody Fusion Surgery: Is There a Difference?

Sponsor: Methodist Health System. Phase: . Conditions: Lumbar Spondylolisthesis, Lumbar Spine Degeneration

full page →ctgov ↗
›RECRUITINGphase readoutNCT05816174: Longitudinal Study of Chronic Postsurgical Pain in Children and Adolescents

Sponsor: Helen Koechlin. Phase: . Conditions: Chronic Post Operative Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT05540574: Trial of Zolpidem for Sleep in Children With Autism

Sponsor: Stanford University. Phase: PHASE2. Conditions: Autism, Autism Spectrum Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT05671874: Feasibility of a Digital Goals-of-Care Decision Aid for Clinicians and Families of Patients With SABI

Sponsor: University of Massachusetts, Worcester. Phase: NA. Conditions: Hemorrhagic Stroke, Intracerebral, Acute Ischemic Stroke, Traumatic Brain Injury

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02905318: Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer

Sponsor: Canadian Cancer Trials Group. Phase: PHASE2. Conditions: Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07477990: Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device in Adult Patients With Moderate to Severe Generalized Anxiety Disorder

Sponsor: Psicofarma, S.A. De C.V.. Phase: PHASE3. Conditions: General Anxiety Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07547397: COMPARISON OF CLASSICAL AND SYRINGE-FREE TECHNIQUES IN ULTRASOUND-GUIDED CENTRAL JUGULAR VENOUS CATHETERIZATION

Sponsor: ALİEMAN. Phase: NA. Conditions: Central Venous Catheters/Standards, Ultrasonography/Methods, Ultrasonography/Standards

full page →ctgov ↗
›RECRUITINGphase readoutNCT07464197: Effectiveness of Dental Bleaching Using Different Designs of 3D-Printed and Conventional Customized Nightguards

Sponsor: Universitat Internacional de Catalunya. Phase: NA. Conditions: Tooth Discoloration, Tooth Staining

full page →ctgov ↗
›RECRUITINGphase readoutNCT07341997: Environmental Factors Associated With Peripheral Neuropathies in French Guiana

Sponsor: Admin CIC. Phase: NA. Conditions: Peripheral Neuropathies, Environmental Risk Factor, Lead Neuropathy, Mercury Neuropathy, Bita

full page →ctgov ↗
›RECRUITINGphase readoutNCT07188610: PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma

Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.. Phase: PHASE2. Conditions: CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT04132310: Mother Infant Nutrition Study

Sponsor: University of Texas at Austin. Phase: . Conditions: Pregnancy Related, Infant Development

full page →ctgov ↗
›RECRUITINGphase readoutNCT07619560: Developing Precision Microbiota-Based Cocktail Modification Therapy to Delay the Progression of Parkinson's Disease (PD) - Use Preclinical Human Trials to Confirm the Impact of the Optimal "Probiotic Y7, Tryptophan and Branched-chain Amino Acid" Cocktail Formula on Early Stage PD Patients

Sponsor: Taipei Medical University. Phase: NA. Conditions: Parkinson Disease (PD), Gut Microbiota, Probiotic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07626320: Effectiveness of a Sound Bowl Meditation on Caregiver Stress and Anxiety

Sponsor: Ohio State University. Phase: NA. Conditions: Stress, Anxiety

full page →ctgov ↗
›COMPLETEDphase readoutNCT06369220: A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections

Sponsor: Hoffmann-La Roche. Phase: NA. Conditions: Chlamydia Trachomatis Infection, Neisseria Gonorrhoeae Infection, Mycoplasma Genitalium Infection

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07661524: Passive Versus Active Music Therapy Parkinson's Disease

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Parkinson Disease (PD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT06795282: Post Operative Sensitivity of MTA Obturation

Sponsor: TC Erciyes University. Phase: . Conditions: Dental Pulp Disease, Endodontically Treated Teeth, Endodontic Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07621224: Multimorbidity and Polypharmacy in People With HIV vs. the General Population in the Basque Country

Sponsor: Biogipuzkoa Health Research Institute. Phase: . Conditions: HIV (Human Immunodeficiency Virus)

full page →ctgov ↗
›RECRUITINGphase readoutNCT04091724: Perioperative EEG-Monitoring and Emergence Delirium in Children

Sponsor: Huazhong University of Science and Technology. Phase: . Conditions: Delirium

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06140823: Prospective Validation of Liver Cancer Risk Computation (LIRIC) Models

Sponsor: Beth Israel Deaconess Medical Center. Phase: . Conditions: Predictive Cancer Model

full page →ctgov ↗
›RECRUITINGphase readoutNCT07327359: A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia

Sponsor: Olix Pharmaceuticals, Inc.. Phase: PHASE1. Conditions: Androgenetic Alopecia (AGA)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07658859: Emotional Freedom Techniques in Nursing Students With Primary Dysmenorrhea

Sponsor: Ataturk University. Phase: NA. Conditions: PRIMARY DYSMENORRHEA

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07298980: ExBRAC- Expressive Writing in Breast Cancer

Sponsor: Region Skane. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
← prev
page 81 of 106
next →